ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,505Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 2604

$1.47M Total Retail Price of All Prescriptions

Rank: 8 out of 2604

608 Patients Receiving at Least One Drug in Part D
22%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

28% of this provider’s 608 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

52% of this provider’s 608 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 2,795 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$118 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SUBOXONE 861 29 10 1 104
HYDROCODONE-ACETAMINOPHEN 822 184 S3 2 1
METHADONE HCL 420 25 S2 3 67
LISINOPRIL 365 119 4 3
GABAPENTIN 296 59 5 12
IBUPROFEN 282 58 6 32
SIMVASTATIN 267 71 7 2
TRAMADOL HCL 266 25 8 15
FUROSEMIDE 247 61 9 8
LEVOTHYROXINE SODIUM 238 51 10 4
PROAIR HFA 220 37 11 27
OMEPRAZOLE 217 78 12 5
METFORMIN HCL 194 33 13 7
CYMBALTA 188 31 14 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 169 19 15 22
NEXIUM 162 44 16 53
SPIRIVA 149 53 17 45
OXYCONTIN 148 32 S2 18 128
RANITIDINE HCL 133 63 19 25
MORPHINE SULFATE ER 133 0 S2 19 58
TRAZODONE HCL 119 19 21 46
LYRICA 119 42 21 79
AMPHETAMINE SALT COMBO 118 0 S2 23 235
OXYCODONE HCL 118 39 S2 23 61
ATENOLOL 115 34 25 11
CYCLOBENZAPRINE HCL 100 0 R 26 43
HYDROCHLOROTHIAZIDE 96 24 27 10
METHOCARBAMOL 96 18 R 27 153
CITALOPRAM HBR 88 18 29 18
METOPROLOL TARTRATE 88 19 29 9
VENTOLIN HFA 81 0 31 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 11 32 91
ADVAIR DISKUS 77 0 33 41
ATORVASTATIN CALCIUM 75 0 34 19
SERTRALINE HCL 72 0 35 23
FLUTICASONE PROPIONATE 67 19 36 31
JANUVIA 64 32 37 98
TAMSULOSIN HCL 64 31 37 30
WARFARIN SODIUM 61 27 39 13
PAROXETINE HCL 61 0 39 62
PANTOPRAZOLE SODIUM 60 0 41 64
DIOVAN HCT 58 0 42 205
AMLODIPINE BESYLATE 58 14 42 6
POLYETHYLENE GLYCOL 3350 57 0 44 42
LIDODERM 56 0 45 80
POTASSIUM CHLORIDE 55 14 46 16
DIPHENOXYLATE-ATROPINE 55 22 46 387
QUETIAPINE FUMARATE 54 0 48 66
ALLOPURINOL 50 19 49 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.